Is 5´-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?

  

Anticancer Activity of the Combination of Cabozantinib and Temozolomide in Uterine Sarcoma

Joseph J. Noh, Young-Jae Cho, Ji-Yoon Ryu, Jung-Joo Choi, Jae Ryoung Hwang, Ju-Yeon Choi, Jeong-Won Lee

Clinical Cancer Research.2022; 28(17): 3850.     CrossRef

The Role of AMPK/mTOR Signaling Pathway in Anticancer Activity of Metformin

Nikola Chomanicova, Andrea Gazova, Adriana Adamickova, Simona Valaskova, Jan Kyselovic

Physiological Research.2021; : 501.     CrossRef

Prognostic value of CLIC3 mRNA overexpression in bladder cancer

Mei Chen, Shufang Zhang, Xiaohong Wen, Hui Cao, Yuanhui Gao

PeerJ.2020; 8: e8348.     CrossRef

Looking to the metabolic landscapes for prostate health monitoring

Wun-Jae Kim, Jayoung Kim

Prostate International.2017; 5(3): 85.     CrossRef

Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cells

SongTao Xiang, QiuHong Zhang, Qing Tang, Fang Zheng, JingJing Wu, LiJun Yang, Swei Sunny Hann

Scientific Reports.2016;[Epub]     CrossRef

AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms

Stavros Kopsiaftis, Poornima Hegde, John A. Taylor, Kevin P. Claffey

Translational Oncology.2016; 9(6): 606.     CrossRef

Application of Oncology Research to Resolve a Problem in Neurourology

Tack Lee

International Neurourology Journal.2015; 19(2): 53.     CrossRef